Rentoertib
Rentoertib has demonstrated improvements in forced vital capacity, a key measure of lung function. AI-generated drugs like rentoertib may offer cost advantages over traditionally developed pharmaceuticals. Rentoertib is an investigational…
1 sources - 4 claims
Rentoertib has demonstrated improvements in forced vital capacity, a key measure of lung function. AI-generated drugs like rentoertib may offer cost advantages over traditionally developed pharmaceuticals. Rentoertib is an investigational IPF medication that is not yet FDA-approved but shows promise in clinical investigation. Rentoertib was developed using artificial intelligence.